# Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis

> **NCT00612014** · PHASE2 · COMPLETED · sponsor: **Tranzyme, Inc.** · enrollment: 78 (actual)

## Conditions studied

- Gastroparesis
- Diabetes Mellitus

## Interventions

- **DRUG:** 5% dextrose in water
- **DRUG:** TZP-101
- **DRUG:** TZP-101
- **DRUG:** TZP-101
- **DRUG:** TZP-101
- **DRUG:** TZP-101

## Key facts

- **NCT ID:** NCT00612014
- **Lead sponsor:** Tranzyme, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-02
- **Final completion:** 2009-03
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2012-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00612014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00612014, "Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00612014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*